Procyon Corporation

PCYN

US7428063009

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 01:08:33 22/06/2024 am IST			5-day change	1st Jan Change
0.294 ^USD	+39.53%		+16.07%	+72.43%

24/05	Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
22/02	Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2021

November 20, 2021 at 03:38 am IST

Procyon Corporation reported earnings results for the first quarter ended September 30, 2021. For the first quarter, the company reported sales was USD 1.19 million compared to USD 1.25 million a year ago. Net income was USD 0.042482 million compared to USD 0.219096 million a year ago.

Latest news about Procyon Corporation

Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	25/05	CI
Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	23/02	CI
Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023	23/11	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2023	29/23/29	CI
Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	16/23/16	CI
Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	15/23/15	CI
Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2022	14/22/14	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2022	29/22/29	CI
Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	12/22/12	CI
Procyon Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	15/22/15	CI
Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2021	20/21/20	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2021	09/21/09	CI
Procyon Corporation Announces Board Changes	21/21/21	CI
Procyon Corporation Announces Resignation of Paul E. Kudelko, Sr. as Board of Directors	12/21/12	CI
Procyon Corporation Reports Earnings Results for the Third Quarter Ended March 31, 2021	25/21/25	CI
Procyon Corporation Reports Earnings Results for the Second Quarter Ended December 31, 2020	26/21/26	CI
Procyon Corporation Enters into Lease for Warehouse and Office in Clearwater, Florida	27/21/27	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2020	06/20/06	CI
Procyon Corporation Reports Earnings Results for the Third Quarter Ended March 31, 2020	25/20/25	CI
Procyon Corporation Reports Earnings Results for the Second Quarter Ended December 31, 2019	20/20/20	CI
Procyon Corporation Reports Earnings Results for the First Quarter Ended September 30, 2019	20/19/20	CI
Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2019	01/19/01	CI
Procyon Corporation Reports Earnings Results for the Third Quarter Ended March 31, 2019	18/19/18	CI
Procyon Corporation Reports Earnings Results for the Second Quarter Ended December 31, 2018	15/19/15	CI
Procyon Corporation Announces Executive Changes	17/18/17	CI

Chart Procyon Corporation

Duration

Period

More charts

Company Profile

Procyon Corporation operates through its subsidiaries AMERX Health Care Corporation (AMERX) and Sirius Medical Supply, Inc. (Sirius). AMERX develops and markets proprietary medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, EXTREMIT-EASE Compression Garment and Advantagen Surgical Collagen. AMERX markets a line of AMERIGEL advanced skin and wound care products made with Oakin, that promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder and Collagen Matrix. Its wound care product includes AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hyrdocolloid Dressing, and AMERX Wound Care Kits.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PROCYON CORPORATION	+72.43%	2.39M
ELI LILLY AND COMPANY	+51.63%	796B
NOVO NORDISK A/S	+41.51%	628B
JOHNSON & JOHNSON	-5.10%	358B
MERCK & CO., INC.	+19.90%	331B
ABBVIE INC.	+9.95%	301B
ASTRAZENECA PLC	+17.66%	244B
ROCHE HOLDING AG	+3.39%	228B
NOVARTIS AG	+10.75%	214B
AMGEN INC.	+6.99%	165B